La Jolla Pharmaceutical Company logo
La Jolla Pharmaceutical Company LJPC

Quarterly report 2022-Q2
added 08-15-2022

report update icon

La Jolla Pharmaceutical Company DSO Ratio 2011-2026 | LJPC

Annual DSO Ratio La Jolla Pharmaceutical Company

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
34.8 63.7 46.9 50.1 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
63.7 34.8 48.9

Quarterly DSO Ratio La Jolla Pharmaceutical Company

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 50.4 62.8 - 59.6 36.2 13.3 - 58.7 91.7 52.9 - 47.3 47.4 45.1 - 36.3 79.1 77.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
91.7 13.3 54.2

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
58.1 $ 333.39 -1.77 % $ 43.7 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 3.17 3.93 % $ 5.22 M israelIsrael
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.73 3.04 % $ 8.97 B australiaAustralia
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 21.68 1.4 % $ 1.01 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
182 - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
62.9 - - $ 399 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.24 2.17 % $ 453 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 24.58 -2.03 % $ 3.13 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.49 0.68 % $ 397 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
164 - -16.75 % $ 25.8 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 33.87 1.62 % $ 2.25 B usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
61.7 - - $ 25.3 M usaUSA
bluebird bio bluebird bio
BLUE
2.47 - - $ 546 M usaUSA